fDPP-4 Level May Be Used As Noninvasive Biomarker Of IBD Activity, Especially In Patients With UC, Study Indicates

Gastroenterology Advisor (5/13, Stong) reports researchers found “fecal dipeptidyl peptidase-4 (fDPP-4) level may be used as a noninvasive biomarker of inflammatory bowel disease (IBD) activity, especially in patients with ulcerative colitis (UC).” The fi...